
TLX101 Demonstrated Efficacy in Recurrent High-Grade Glioma
Treatment with TLX101 (131I-iodofalan1) elicited efficacy in recurrent high-grade glioma, a type of brain cancer, according to preliminary results from the phase 2 IPAX-Linz study which were shared in a press release from Telix Pharmaceuticals Limited. …